Vir Biotechnology
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1800 Owens St Ste 900, San Francisco, Ca...Phone Number
(415) 906-4324Website
vir.bioRevenue
$64.7 MillionStock Symbol
VIRIndustry
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
4
4
1
1
2
3
About Vir Biotechnology
Vir Biotechnology is a clinical-stage biopharmaceutical company focused on developing innovative medicines that harness the immune system to treat serious diseases. Its research combines immunology with advanced antibody engineering and immune-modulating technologies, with programs spanning infectious diseases and oncology. Vir’s pipeline includes therapies targeting chronic hepatitis and cancer, supported by proprietary platforms designed to discover, engineer, and advance novel treatments from research through clinical development.Explore more
Vir Biotechnology Org Chart
EK
Vice President & Chief of Staff & Chief Marke...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vir Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Vir Biotechnology had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Vir Biotechnology launches new products
Earning: See what the market has to say on Vir Biotechnology recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Vir Biotechnology
Funding: Get notified immidiatlly once Vir Biotechnology has new funding data
Check if Vir Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Check out if Vir Biotechnology is spiking on competitors!
Vir Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Vir Biotechnology as Masked Content
Find more new buyers
Compare Similar Companies to Vir Biotechnology
Compare insights from companies similar to Vir Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vir Biotechnology
$64.7M
201-500
Public
$260M
2016
DB
Deborah BartonSenior Chief Marketing Officer, EA Office of & Corporate Communications Business Partner
Company Profile Activity
Activity Insights
Vir Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vir Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vir Biotechnology.
Vir Biotechnology financials insights
Gather financial insights about Vir Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$250M
2023
Grant
$10M
Vir Biotechnology Tech Stack
A closer look at the technologies used by Vir Biotechnology
Most Recent Scoops
Open Position
Open Position
Hiring Plans
VIR has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Vir Biotechnology News & Media
Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Timothy Coughlin to its Board of Directors and as Chair of the Audit Committee, effective June 9, 2026. “We are pleased to welcome Tim to Vir Biotechnology’s Board of Directors at a pivotal moment for the company,” said Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, Vir Biotechnology. “Tim brings a strong background of strategic discipline and operational insight that has helped organizations evolveIs Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on Valueinvestorsclub.com by Bohr. In this article, we will summarize the bulls’ thesis on VIR. Vir Biotechnology, Inc.’s share was trading at $9.19 as of May 25th. VIR’s trailing P/E was 5.92 according to Yahoo Finance. Vir Biotechnology, Inc., a […]Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
Vir Biotechnology develops immunology-based therapies targeting infectious diseases through global partnerships and scientific innovation.Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 Million
Vir Biotechnology develops immunology-based therapies for infectious diseases, backed by collaborations and a diversified research pipeline.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vir Biotechnology
Sign Up For FreeTo access detailed company insights
Vir Biotechnology is a clinical-stage biopharmaceutical company focused on developing innovative medicines that harness the immune system to treat serious diseases. Its research combines immunology with advanced antibody engineering and immune-modulating technologies, with programs spanning infectious diseases and oncology. Vir’s pipeline includes... Read More
